AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $137,000 | +22.3% | 47,258 | -39.3% | 0.00% | 0.0% |
Q1 2019 | $112,000 | -44.3% | 77,918 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $201,000 | -41.2% | 77,918 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $342,000 | -28.5% | 77,918 | 0.0% | 0.01% | -16.7% |
Q2 2018 | $478,000 | -15.8% | 77,918 | 0.0% | 0.01% | -25.0% |
Q1 2018 | $568,000 | -11.1% | 77,918 | 0.0% | 0.01% | -11.1% |
Q4 2017 | $639,000 | -21.9% | 77,918 | 0.0% | 0.01% | -25.0% |
Q3 2017 | $818,000 | -4.8% | 77,918 | 0.0% | 0.01% | -7.7% |
Q2 2017 | $859,000 | +13.9% | 77,918 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $754,000 | – | 77,918 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,673,718 | $20,949,000 | 10.15% |
Vivo Capital, LLC | 3,575,424 | $28,389,000 | 2.57% |
COWEN AND COMPANY, LLC | 1,517,296 | $10,767,000 | 2.47% |
VR Adviser, LLC | 1,057,827 | $8,399,000 | 2.28% |
RTW INVESTMENTS, LP | 4,616,570 | $36,253,000 | 1.56% |
GENDELL JEFFREY L | 553,516 | $4,395,000 | 1.35% |
Avoro Capital Advisors LLC | 4,365,655 | $34,663,000 | 1.17% |
Arlington Capital Management, Inc. | 115,902 | $920,000 | 0.85% |
Ghost Tree Capital, LLC | 350,000 | $2,779,000 | 0.74% |
PURA VIDA INVESTMENTS, LLC | 496,660 | $3,943,000 | 0.47% |